Igor Spurnić
Impact in
-
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- IL-33, ST2, and ILC Pathways
- Immunotherapy and Immune Responses
- Immune cells in cancer
-
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
-
- Lung Cancer Treatments and Mutations 2
- Lung Cancer Diagnosis and Treatment 1
- Oncology 2
- Cancer Immunotherapy and Biomarkers 1
- Co-authors
- Ana Vuletić (2 shared papers)Zorka Milovanović (3 shared papers)Vladimir Jurišić (2 shared papers)Srdjan Nikolić (4 shared papers)Gordana Konjević (2 shared papers)Merima Goran (3 shared papers)Nasta Tanić (1 shared paper)Ana Cvetković (2 shared papers)
- Journals
- Pathology & Oncology Research (2 papers)European Journal of Surgical Oncology (1 paper)Life (1 paper)Medicinski pregled (1 paper)PubMed (3 papers)
- Partner nations
- Serbia
In The Last Decade
Igor Spurnić
8 papers receiving 66 citations
Peers
Comparison fields: 5 of 24
- Immunology 41
- Oncology 30
- Parasitology 4
- Gastroenterology 3
- Pulmonary and Respiratory Medicine 13
Countries citing papers authored by Igor Spurnić
This map shows the geographic impact of Igor Spurnić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Igor Spurnić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Igor Spurnić more than expected).
Fields of papers citing papers by Igor Spurnić
This network shows the impact of papers produced by Igor Spurnić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Igor Spurnić. The network helps show where Igor Spurnić may publish in the future.
Co-authors
The 19 scholars most cited alongside Igor Spurnić, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 29 | |
| 2 | 2015 | 17 | |
| 3 | 2024 | 8 | |
| 4 | Hyperthermic intrathoracic chemotherapy (HITHOC) in ovarian carcinoma - a propos of a case. | 2018 | 6 |
| 5 | 2015 | 4 | |
| 6 | 2018 | 1 | |
| 7 | 2020 | 1 | |
| 8 | Factors related to local recurrence of non small cell lung cancer and its operability. | 2016 | 1 |
About Igor Spurnić
Igor Spurnić is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Biotechnology, Immunology and Infectious Diseases, having authored 8 papers that have together received 67 indexed citations. Recurring topics across this work include Cancer Research and Treatments (2 papers), Lung Cancer Treatments and Mutations (2 papers), Immunotherapy and Immune Responses (2 papers), T-cell and B-cell Immunology (2 papers), Immune Cell Function and Interaction (2 papers), Neuroblastoma Research and Treatments (1 paper), Cancer Immunotherapy and Biomarkers (1 paper) and Lung Cancer Diagnosis and Treatment (1 paper). The work is most often cited by research in Immunology (41 citations), Oncology (30 citations), Parasitology (4 citations), Gastroenterology (3 citations) and Pulmonary and Respiratory Medicine (13 citations). Igor Spurnić has collaborated with scholars based in Serbia. Frequent co-authors include Ana Vuletić, Zorka Milovanović, Vladimir Jurišić, Srdjan Nikolić, Gordana Konjević, Merima Goran, Nasta Tanić, Ana Cvetković, D. Stojiljkovic and Ivan Marković. Their work appears in journals such as Pathology & Oncology Research, European Journal of Surgical Oncology, Life, Medicinski pregled and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.